Hematology/Oncology
RSSArticles
-
FDA Approves AI Tool to Help Detect Colon Cancer
Machine learning gives clinicians another tool while trying to detect troubling signs during routine screening.
-
Ongoing Ethical Concerns with Misleading Advertising by Cancer Centers
Recent guidance outlines ethical concerns when cancer centers advertise directly to the public. The authors recommend these centers ensure fair and balanced promotion of cancer services, avoid exaggeration of claims, and provide data and statistics to support direct and implied assertions of treatment success.
-
Elderly Patients with Esophageal Cancers Might Tolerate Multimodal Therapy Well
Some clinicians shy away from complete therapy courses for these patients over concerns about frailty, quality of life.
-
Relugolix Tablets (Orgovyx)
Relugolix should be prescribed to adults with advanced prostate cancer.
-
Report: Record Year-Over-Year Decline in Cancer Death Rate
Fewer smokers, better detection and treatment methods credited with saving lives.
-
Statins as a Protector Against Chemotherapy
Women with early stage breast cancer shield their hearts with cholesterol-lowering drug.
-
Delayed Screenings Correlate with More Severe Lung Cancer Malignancies
COVID-19 led to canceled or delayed care in 2020 — with consequences.
-
Expanded Medicaid Led to Better Outcomes for Colon Cancer Patients
News arrives after USPSTF recommended expanding eligible starting age for colon cancer screening.
-
State Support Could Improve HPV Vaccination Rates
Investigators researched three possible state-level programs to guide lawmakers on this public health issue.
-
Pralsetinib Capsules (Gavreto)
Pralsetinib should be prescribed to treat adults with metastatic RET, fusion-positive non-small cell lung cancer.